Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?

Luis J. Jara, Olga Vera-Lastra, Naim Mahroum, Carlos Pineda, Yehuda Shoenfeld

Research output: Contribution to journalArticlepeer-review

Abstract

To date, around 60% of the world population has been protected by vaccines against SARS-CoV-2, significantly reducing the devastating effect of the pandemic and restoring social economic activity through mass vaccination. Multiple studies have demonstrated the effectiveness and safety of vaccines against COVID-19 in healthy populations, in people with risk factors, in people with or without SARS-CoV-2 infection, and in immunocompromised people. According to the criteria for post-vaccine adverse events established by the World Health Organization, a minority of individuals may develop adverse events, including autoimmune syndromes. The exact mechanisms for the development of these autoimmune syndromes are under study, and to date, a cause-effect relationship has not been established. Many of these autoimmune syndromes meet sufficient criteria for the diagnosis of Adjuvant-Induced Autoimmune Syndrome (ASIA syndrome). The descriptions of these autoimmune syndromes open new perspectives to the knowledge of the complex relationship between the host, its immune system, with the new vaccines and the development of new-onset autoimmune syndromes. Fortunately, most of these autoimmune syndromes are easily controlled with steroids and other immunomodulatory medications and are short-lived. Rheumatologists must be alert to the development of these autoimmune syndromes, and investigate the relationship between autoimmune/inflammatory symptoms and vaccination time, and assess their therapeutic response.

Original languageEnglish
Pages (from-to)1603-1609
Number of pages7
JournalClinical Rheumatology
Volume41
Issue number5
DOIs
StatePublished - May 2022
Externally publishedYes

Keywords

  • Adverse event vaccine
  • Autoimmune diseases
  • Autoimmune/inflammatory syndrome induced by adjuvants (ASIA syndrome)
  • Autoimmunity
  • COVID-19 vaccine

Fingerprint

Dive into the research topics of 'Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?'. Together they form a unique fingerprint.

Cite this